ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 98 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $51,788 | -96.4% | 10,789 | -94.4% | 0.00% | -100.0% |
Q2 2023 | $1,452,997 | -7.3% | 193,475 | -44.2% | 0.00% | 0.0% |
Q1 2023 | $1,567,487 | -59.4% | 346,789 | +1.3% | 0.00% | -50.0% |
Q4 2022 | $3,858,341 | +17.8% | 342,355 | +0.0% | 0.00% | 0.0% |
Q3 2022 | $3,275,000 | +18.4% | 342,213 | +0.1% | 0.00% | 0.0% |
Q2 2022 | $2,765,000 | -52.4% | 341,819 | -0.5% | 0.00% | -33.3% |
Q1 2022 | $5,807,000 | +2270.2% | 343,663 | +2909.3% | 0.00% | – |
Q4 2021 | $245,000 | -78.8% | 11,420 | -26.9% | 0.00% | -100.0% |
Q3 2021 | $1,153,000 | +87.2% | 15,623 | +38.7% | 0.00% | – |
Q2 2021 | $616,000 | -28.0% | 11,263 | -3.0% | 0.00% | – |
Q1 2021 | $855,000 | +39.0% | 11,608 | +62.8% | 0.00% | – |
Q4 2020 | $615,000 | +218.7% | 7,132 | +39.6% | 0.00% | – |
Q3 2020 | $193,000 | – | 5,108 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 9,699,925 | $46,559,640 | 13.20% |
Vivo Capital, LLC | 4,220,048 | $20,256,230 | 2.22% |
Logos Global Management LP | 1,000,000 | $4,800,000 | 0.64% |
Orbimed Advisors | 2,871,000 | $13,780,800 | 0.29% |
Redmile Group, LLC | 1,283,289 | $6,159,787 | 0.29% |
BRAIDWELL LP | 1,249,900 | $5,999,520 | 0.19% |
Cormorant Asset Management, LP | 612,079 | $2,937,979 | 0.17% |
Nan Fung Group Holdings Ltd | 41,950 | $201,360 | 0.16% |
Forefront Analytics, LLC | 13,769 | $66,092 | 0.04% |
CORNERCAP INVESTMENT COUNSEL INC | 35,071 | $168,341 | 0.03% |